Realbotix Reports Financial Results for Q2-2026
Go back to Realbotix Reports Financial Results for Q2-2026| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 1.02 +0.28 (37.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.74 | 52 Week High | $0.00 | |||
| Open | $0.74 | 52 Week Low | $0.00 | |||
| Day High | $1.05 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $0.00 | |||
| Volume | 6,586,958 | |||||
| (AMEX: XBOTF) | Delayed: 0.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.20 | 52 Week High | $ | |||
| Open | $0.20 | 52 Week Low | $ | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.20 | EPS | $ | |||
| Volume | 483,481 | |||||
